• SearchCtrl + K

  • Patients
  • Tasks
  • Audits
  • Shared with me
  • Spaces
  • Templates
  • Coding standards
  • Product demos
  • Compliance
  • Benefits calculator
    1. Community
    2. Templates
    3. General Practice
    4. General Practice Chronic Condition Plan template and example

    General Practice Chronic Condition Plan template and example

    Created by

    Andrew Kelly

    Specialty

    General Practice

    Last edited

    10/28/2026

    Uses

    0 times

    Tags

    General Practice

    About this template

    A structured template for documenting a General Practice Management Plan for a patient with a chronic condition. It covers patient and GP details, assessment, relevant history, current needs, goals, agreed actions, lifestyle measures, monitoring, medications, immunisations, complications, and mental health and wellbeing.

    Learn more about Rhazes templates

    Preview template

    GP Management Plan - Chronic Obstructive Pulmonary Disease (COPD)

    Patient Details

    • Full Name: Arthur James Pendelton
    • Date of Birth: 14/05/1952
    • Medicare Number: 2491 83746 1 (Ref: 1)
    • Does the patient identify as Aboriginal or Torres Strait Islander: No
    • Address: 42 Banksia Street, Heidelberg VIC 3084
    • Home Phone: (03) 9459 1122
    • Mobile Phone: 0412 398 765

    Date GPMP Completed: 18/10/2023

    Date of Previous GPMP: 12/10/2022

    Details of Patient's Usual GP

    • Name: Dr Sarah Jenkins
    • Qualifications: MBBS, FRACGP
    • GP's Address: Heidelberg Medical Centre, 110 Burgundy Street, Heidelberg VIC 3084
    • GP's Phone: (03) 9459 8800
    • GP's Fax: (03) 9459 8801

    Assessment of Patient

    Patient Identified Problems / Health Care Needs

    • Diagnosis: Chronic Obstructive Pulmonary Disease (COPD) - GOLD Stage II (Moderate)
    • Date of Diagnosis: 15/06/2019

    Medical / Surgical History:

    • Hypertension (diagnosed 2015)
    • Hyperlipidaemia (diagnosed 2016)
    • Osteoarthritis of bilateral knees
    • Hospital admission: Austin Hospital (07/2022) for infective exacerbation of COPD
    • Appendicectomy (1978)

    Medications:

    • umeclidinium/vilanterol (Anoro Ellipta®) 62.5/25 mcg INH Mane
    • salbutamol (Ventolin®) 100 mcg MDI 1–2 puffs PRN for SOB
    • perindopril (Coversyl®) 5 mg PO Mane
    • atorvastatin (Lipitor®) 20 mg PO Nocte
    • paracetamol (Panadol Osteo®) 665 mg PO 2 tabs TID PRN

    Allergies:

    • amoxicillin: maculopapular rash

    Immunisation History: The patient's vaccinations are currently up to date. He received the annual quadrivalent influenza vaccine on 20/04/2023 and the 13-valent pneumococcal conjugate vaccine (Prevenar 13®) on 10/05/2022. He has completed his primary COVID-19 vaccination course and received a booster dose on 15/03/2023.

    Smoking History: The patient is a current smoker with a 40 pack-year history, currently smoking approximately 10 cigarettes per day. He has made two previous quit attempts using nicotine replacement therapy, most recently in 2021.

    Planned Review Date: 18/04/2024

    GPMP Added to the Patient's Records: Yes

    Copy of GPMP Offered to Patient: Yes

    Patient Understanding and Agreement

    "I understand this Management Plan recommendations and agree to the outlined goals."

    Patient Signature: A. J. Pendelton

    Date: 18/10/2023

    "I have explained the steps and costs involved, and the patient has agreed to proceed with the service."

    GP Signature: Dr Sarah Jenkins (Electronically Signed)

    Date: 18/10/2023

    Current Health Need/Problem: The patient experiences persistent exertional dyspnoea (mMRC Grade 2) and a chronic productive morning cough, alongside ongoing tobacco dependence which accelerates his lung function decline. He requires support with smoking cessation, maintenance of inhaler adherence, and pulmonary rehabilitation to prevent further acute exacerbations.

    Goal: Achieve complete smoking cessation within 6 months, reduce mMRC dyspnoea score from Grade 2 to Grade 1, and prevent any hospital admissions or moderate-to-severe exacerbations over the next 12 months.

    Agreed Action by Health Professionals and Patient

    1. General

      • Patient's Understanding of the Condition: The patient demonstrates a fair understanding of COPD and its progressive nature, which was confirmed using the teach-back method during today's consultation. Written educational material from the Lung Foundation Australia, including a written COPD Action Plan, was provided and explained. A follow-up appointment with the practice nurse is scheduled in 4 weeks to reinforce self-management strategies and review early signs of an exacerbation.
    2. Lifestyle

      • Quality of Life: Evaluating the condition's effect on quality of life is essential to track functional decline and treatment efficacy. The COPD Assessment Test (CAT) was administered today (baseline score: 16) and will be re-applied every 6 months at GPMP review appointments to monitor changes over time.
      • Nutrition: Education was provided regarding a high-protein, balanced diet to maintain a healthy BMI (currently 23.5 kg/m²) and preserve respiratory muscle mass. The patient was advised to eat smaller, more frequent meals to avoid postprandial bloating and diaphragmatic splinting. No formal dietitian referral is required at this stage, though weight will be monitored at each visit.
      • Physical Activity/Exercise: The primary aim is to improve exercise tolerance and reduce exertional breathlessness through regular aerobic and resistance training. The patient is advised to undertake brisk walking for 20–30 minutes at least 5 days per week. A referral has been generated for the Austin Health Outpatient Pulmonary Rehabilitation Program to commence next month.
      • Smoking Cessation: The primary objective is complete smoking cessation with a target quit date set for 01/11/2023. Combination nicotine replacement therapy (nicotine patch 21 mg/24 hr daily plus nicotine lozenge 2 mg PRN) has been initiated alongside brief behavioural counselling. The patient has been referred to Quitline (13 78 48) for ongoing telephone coaching and behavioural support.
      • Energy Conservation: Education was provided regarding pacing strategies, pursed-lip breathing, and seated showering to minimise dyspnoea during activities of daily living. The patient has been referred to a local occupational therapist via a Team Care Arrangement for a home assessment and further practical support with energy conservation techniques.
    3. Biochemical

      • Spirometry: Spirometry is utilised to objectively assess airflow limitation and track disease progression using the post-bronchodilator FEV1/FVC ratio and FEV1 percentage predicted to classify severity. Baseline spirometry was completed on 10/10/2023 (post-BD FEV1/FVC 0.58, FEV1 62% predicted), and repeat testing is scheduled annually, with the next assessment due in October 2024.
    4. Medication

      • Medication Review: Medications are reviewed at every 6-month GPMP review to ensure optimal bronchodilation and minimise side effects; the patient remains stable on umeclidinium/vilanterol (Anoro Ellipta®) and PRN salbutamol (Ventolin®). Inhaler technique for both the Ellipta device and MDI with spacer was checked today and confirmed to be satisfactory. A Home Medicines Review (HMR) by an accredited pharmacist is planned within the next 2 months to further support adherence.
      • Immunisation: Required vaccinations are currently up to date, with the most recent influenza vaccine administered on 20/04/2023 and Prevenar 13® on 10/05/2022. The next seasonal influenza vaccine is planned for April 2024, and the first dose of the 23-valent pneumococcal polysaccharide vaccine (Pneumovax 23®) is scheduled for May 2024. The Recombinant Zoster Vaccine (Shingrix®) has also been recommended for discussion at the next visit.
    5. Complications

      • Monitoring of Health Conditions: Regular monitoring will focus on detecting early infective exacerbations, hypoxia, cardiovascular comorbidities, and osteoporosis risk (secondary to smoking and intermittent oral corticosteroid use). Annual FBE, UEC, fasting lipids, and a baseline DEXA scan for bone mineral density have been ordered, alongside routine resting SpO2 and BP checks at each clinic visit. The patient was advised to maintain adequate hydration and avoid respiratory irritants, with a respiratory physician referral planned if FEV1 declines below 50% or if he experiences ≥ 2 exacerbations per year.
    6. Mental Health and Wellbeing

      • Depression, Anxiety, and Stress: The patient was assessed for mood disturbances associated with chronic breathlessness using the Kessler Psychological Distress Scale (K10), scoring 18 (indicating mild distress). Breathing relaxation techniques were discussed to help manage acute breathlessness-induced anxiety. No formal psychology referral is required currently, though mood will be re-screened at the 6-month review.
      • Social Isolation and Emotional Wellbeing: The patient is encouraged to maintain active engagement with his family and local bowls club to prevent social isolation. Contact details for the Lung Foundation Australia Peer Support Program (1800 654 301) and the local Banyule Community Health respiratory support group were provided. Access to a community social worker will be arranged if his functional status declines in the future.

    How to use this template

    Select “Use this template” to add it to your library. You can then adjust it to suit how you work, and the example above shows the kind of note it produces.

    Tags

    General Practice

    Related templates

    • Well Child Check template
      A reusable template for documenting routine infant and child health assessments, including history, growth, nutrition, development, examination, screening, immunizations, and follow-up planning. It supports structured recording of caregiver concerns and preventive guidance during well-child visits.

      General Practice

    • Abnormal Uterine Bleeding template
      A reusable template for comprehensively documenting abnormal uterine bleeding in general practice. It covers the presenting history, relevant medical and family history, menstrual and reproductive screening, examination, investigations, and explicitly stated assessment and management plans.

      General Practice

    • Medicolegal Report template
      A structured template for preparing comprehensive medical reports for legal purposes. It covers patient and referral details, the report’s purpose, clinical history, examination, investigations, diagnosis, professional opinion, recommendations, conclusion, and clinician sign-off.

      General Practice

    • Diabetes Check-up template
      A reusable template for documenting diabetes-focused consultations, including patient details, diabetes and family history, medicines, measurements, examination findings, investigations, and follow-up planning. It supports consistent recording of treatment decisions and ongoing diabetes monitoring.

      General Practice

    • Patient Consultation Summary template
      A patient-friendly template for summarising the main issues discussed, explicitly stated diagnoses, management plans and patient tasks from a general practice consultation. It supports clear communication about treatment and follow-up without using medical abbreviations or jargon.

      General Practice

    • Aesthetic Consultation Form template
      This template is used to document consultations for aesthetic treatments. It covers patient and consultation details, aesthetic concerns, examination findings, the proposed treatment plan, consent, and clinician information.

      General Practice

    General Practice templatesView all 622 templates